TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20817823

Group type: EXPERIMENTAL
Intervention: Primed acceptance cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonlonely individuals
Number of subjects: 0
Study: 17716273

Group type: EXPERIMENTAL
Intervention: Pulse-modulated EMF exposure at 0.2 W kg(‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pulse-modulated EMF exposure at 5 W kg(‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 15
Study: 15848570

Group type: EXPERIMENTAL
Intervention: Basiliximab (Simulect)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study: 12460126

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Family Support Network (FSN)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach (ACRA)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 600
Study: 10509549

Group type: EXPERIMENTAL
Intervention: Fenoldopam at 0.04 microg/kg/min
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Fenoldopam at 0.8 microg/kg/min
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Fenoldopam (general)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 33
Study: 7859936

Group type: EXPERIMENTAL
Intervention: Low-dose bedtime insulin/daytime sulfonylurea (BI-DSU)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-dose bedtime insulin plus daytime sulfonylurea (BI-DSU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-dose bedtime insulin alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Daytime sulfonylurea alone
Number of subjects: 30
Study: 1659505

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 20
Study: 7278218

Group type: EXPERIMENTAL
Intervention: Depth jump
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Box drill
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Flexibility-agility exercise
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (warmup)
Number of subjects: 160
Study: 30820059

Group type: EXPERIMENTAL
Intervention: Endo-cut I mode
Number of subjects: 0

Group type: COMPARATOR
Intervention: Swift-coagulation mode
Number of subjects: 0
Study: 28176336

Group type: EXPERIMENTAL
Intervention: Hypothermic machine perfusion (HMP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Common static cold preservation (CCP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 25873064

Group type: EXPERIMENTAL
Intervention: everolimus (trough levels 3-8 ng/mL) with reduced tacrolimus (trough levels <5 ng/mL)
Number of subjects: 330

Group type: COMPARATOR
Intervention: standard tacrolimus (trough levels 6-10 ng/mL)
Number of subjects: 330
Study: 23377343

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fat grafting
Number of subjects: 20
Study: 21349680

Group type: EXPERIMENTAL
Intervention: Intervention providing alliance and outcome feedback to counselors
Number of subjects: 1613
Study: 19822825

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus medroxyprogesterone acetate (0.625 mg + 2.5 mg)
Number of subjects: 14538

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus medroxyprogesterone acetate
Number of subjects: 14538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14538
Study: 16618486

Group type: EXPERIMENTAL
Intervention: Short-messaging service (SMS) intervention for 12 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no SMS intervention)
Number of subjects: 51
Study: 15574078

Group type: EXPERIMENTAL
Intervention: 3 g of beta-hydroxy beta-methylbutyrate (HMB) per day
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 12954467

Group type: EXPERIMENTAL
Intervention: Severe Respiratory Insufficiency (SRI) Questionnaire
Number of subjects: 226
Study: 10409125

Group type: EXPERIMENTAL
Intervention: DCA (100 mg/kg body mass)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 6
Study: 8643332

Group type: EXPERIMENTAL
Intervention: Pro-saccade trials with a cue lead time of 100 ms
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Pro-saccade trials with a cue lead time of 200 ms
Number of subjects: 5

Group type: COMPARATOR
Intervention: Test sessions without preinformative cues
Number of subjects: 5
Study: 2384080

Group type: EXPERIMENTAL
Intervention: CM40907
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7317296

Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dust exposure (tea and wood)
Number of subjects: 0
Study: 31559633

Group type: EXPERIMENTAL
Intervention: Early movement (EM) - tooth extracted 1 week before space closure initiation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Delayed movement (DM) - tooth extracted 8 weeks before space closure initiation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fast movers - tooth movement ≥1 mm per month
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Slow movers - tooth movement <1 mm per month
Number of subjects: 25
Study: 11757002

Group type: EXPERIMENTAL
Intervention: Computer-assisted system (active group)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Computer-assisted system with grafting (graft group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Empirical repositioning method (control group)
Number of subjects: 31
Study: 30126085

Group type: EXPERIMENTAL
Intervention: RespiraSense™
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Capnography
Number of subjects: 17

Group type: COMPARATOR
Intervention: Manual counts
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: RespiraSense™ vs Capnography
Number of subjects: 17
Study: 26449197

Group type: EXPERIMENTAL
Intervention: Community optometrists making lesion reactivation decisions
Number of subjects: 96
Study: 24384646

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen-based hormone therapy (HT)
Number of subjects: 729

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 729
Study: 22648840

Group type: EXPERIMENTAL
Intervention: Early oral feeding with enteral nutrition preparation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional postoperative care protocol
Number of subjects: 60
Study: 20395537

Group type: EXPERIMENTAL
Intervention: Darifenacin ER 7.5 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Darifenacin ER 15 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Tolterodine 4 mg
Number of subjects: 72
Study: 18713926

Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/kg followed by 42 microg x kg(‐1) x h(‐1) (ketamine-1 group)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/kg followed by 83 microg x kg(‐1) x h(‐1) (ketamine-2 group)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (no ketamine)
Number of subjects: 3
Study: 15957569

Group type: EXPERIMENTAL
Intervention: MEMS feedback group (bupropion‐SR 150 mg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No-feedback group (placebo)
Number of subjects: 97
Study: 12391068

Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg twice daily for 5 doses)
Number of subjects: 9
Study: 11099326

Group type: EXPERIMENTAL
Intervention: recombinant vaccinia (rV)‐CEA followed by three avipox‐CEA vaccinations
Number of subjects: 18

Group type: COMPARATOR
Intervention: avipox‐CEA (three times) followed by one rV‐CEA vaccination
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: local granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and low‐dose interleukin (IL)‐2 with subsequent vaccinations
Number of subjects: 18
Study: 9065257

Group type: EXPERIMENTAL
Intervention: Ro 48-6791
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 0
Study: 1642024

Group type: EXPERIMENTAL
Intervention: Piroxicam (0.3 mg/kg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Diclofenac (1 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6365599

Group type: EXPERIMENTAL
Intervention: Loupe (n = 36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Microscope (n = 36)
Number of subjects: 72
Study: 31498393

Group type: EXPERIMENTAL
Intervention: Reboot Online (8-lesson multidisciplinary pain management program)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 80
Study: 27820726

Group type: EXPERIMENTAL
Intervention: HMB supplementation (n = 13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 27
Study: 27450591

Group type: EXPERIMENTAL
Intervention: Voluntary medical male circumcision (VMMC)
Number of subjects: 40
Study: 25115136

Group type: EXPERIMENTAL
Intervention: Web-based multimedia training
Number of subjects: 92

Group type: COMPARATOR
Intervention: Comparable reading materials
Number of subjects: 92
Study: 22466461

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (0.3 mg or 0.5 mg)
Number of subjects: 145
Study: 20298639

Group type: EXPERIMENTAL
Intervention: Grade 1 reading intervention
Number of subjects: 236
Study: 18031482

Group type: EXPERIMENTAL
Intervention: Childhood physical abuse
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Both childhood sexual and physical abuse
Number of subjects: 21000
Study: 15968551

Group type: EXPERIMENTAL
Intervention: Lateral femoral cutaneous nerve (LFCN) block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Femoral nerve (FN) block
Number of subjects: 40
Study: 12161042

Group type: EXPERIMENTAL
Intervention: 80 mg isoflavones (Promensil)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10519337

Group type: EXPERIMENTAL
Intervention: Lignocaine-prilocaine cream (EMLA)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Amethocaine gel (Ametop)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 34
Study: 7864266

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 8443031

Group type: EXPERIMENTAL
Intervention: Digoxin tablets (250 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Liquid filled digoxin capsules (100 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Experimental enteric-coated capsule (100 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous control
Number of subjects: 12
Study: 2428462

Group type: EXPERIMENTAL
Intervention: BCVPP-Bleo (BCNU, cyclophosphamide, vinblastine, procarbazine, prednisone, and bleomycin)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Alternating regimen (same drugs alternating in monthly cycles with doxorubicin, dacarbazine, and bleomycin)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 212
Study: 29477574

Group type: EXPERIMENTAL
Intervention: HCV screening, education, and care coordination (active linkage intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HCV screening and education (control)
Number of subjects: 0
Study: 27769563

Group type: EXPERIMENTAL
Intervention: Regenerex (novel porous titanium construct)
Number of subjects: 61

Group type: COMPARATOR
Intervention: PPS (porous plasma sprayed tibial component)
Number of subjects: 61
Study: 25954758

Group type: EXPERIMENTAL
Intervention: Biphasic SHB (60% HA/40% bTCP) with aPRF
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Monophasic SHB (100% bTCP) with aPRF
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Biphasic SHB (60% HA/40% bTCP) without aPRF
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Monophasic SHB (100% bTCP) without aPRF
Number of subjects: 82
Study: 23318149

Group type: EXPERIMENTAL
Intervention: Intranasal H1N1 vaccine
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study: 21307169

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 2502

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in symptomatic patients
Number of subjects: 2502

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA) in symptomatic patients
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) in asymptomatic patients
Number of subjects: 2502

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA) in asymptomatic patients
Number of subjects: 2502
Study: 19185140

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass
Number of subjects: 349

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting with cardiopulmonary bypass
Number of subjects: 349
Study: 16999610

Group type: EXPERIMENTAL
Intervention: Blind access and totally tubeless percutaneous nephrolithotomy (PCNL)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pneumatic transurethral ureterolithotripsy
Number of subjects: 70
Study: 15298243

Group type: EXPERIMENTAL
Intervention: Profile Soft‐Seal Cuff (Permeable: P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Portex Soft‐Seal Cuff (Resistant: R)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (P and R)
Number of subjects: 40
Study: 11093564

Group type: EXPERIMENTAL
Intervention: Expectant mothers' anticipated workload increase
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Expectant fathers' anticipated workload increase
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Postpartum work hours planned by women
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Satisfaction with partner's contribution to household work
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Congruency in partners' perceptions of household work sharing
Number of subjects: 149
Study: 9520161

Group type: EXPERIMENTAL
Intervention: Immediate zidovudine treatment
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 7997375

Group type: EXPERIMENTAL
Intervention: D2 receptor scintigraphy (123I-IBZM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cerebral perfusion (99m-Tc-HMPAO)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Huntington's chorea patients
Number of subjects: 26
Study: 2895483

Group type: COMPARATOR
Intervention: Remoxipride 150‐600 mg/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29131129

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27036379

Group type: EXPERIMENTAL
Intervention: Glucocorticoids (GC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tocilizumab (TCZ)
Number of subjects: 0
Study: 25539805

Group type: EXPERIMENTAL
Intervention: Alternative-mechanism TNF-inhibitor (TNFi) or abatacept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 0
Study: 22061867

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Community treatment by experts
Number of subjects: 101
Study: 21092191

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1510

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1510
Study: 18707799

Group type: EXPERIMENTAL
Intervention: Topical methyl-aminolevulinate (MAL) cream applied under occlusion for 3 hours, followed by illumination with red light-emitting diode (630 nm, light dose 37 J/cm2)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Vehicle cream applied under occlusion for 3 hours, followed by illumination with red light-emitting diode (630 nm, light dose 37 J/cm2)
Number of subjects: 49
Study: 15975990

Group type: EXPERIMENTAL
Intervention: 0.5% rapamycin-eluting stent
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: 1.0% rapamycin-eluting stent
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: 2.0% rapamycin-eluting stent
Number of subjects: 602

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 602
Study: 12208437

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride and buffered lidocaine
Number of subjects: 40
Study: 9717924

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo acupuncture needle
Number of subjects: 60
Study: 2717521

Group type: EXPERIMENTAL
Intervention: 30 mg oral ketorolac tromethamine (KT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 mg intramuscular ketorolac tromethamine (KT)
Number of subjects: 12
Study: 1015602

Group type: EXPERIMENTAL
Intervention: Atropine 0.6 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Atropine 0.6 mg and Metoclopramide 10 mg in combination
Number of subjects: 3
Study: 31740074

Group type: EXPERIMENTAL
Intervention: Multidimensional intervention (home visits and telephone follow-up for 5 months)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Multidimensional intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 154
Study: 31139877

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 1691

Group type: COMPARATOR
Intervention: CYP inducers (concurrent medication)
Number of subjects: 1691

Group type: COMPARATOR
Intervention: CYP3A4 inhibitors (co-medications)
Number of subjects: 1691

Group type: COMPARATOR
Intervention: Gender (female)
Number of subjects: 1691
Study: 28121185

Group type: EXPERIMENTAL
Intervention: Exercise (EX) post-HFM at 60% peak oxygen uptake on a treadmill for 1 h
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sedentary (CON) post-HFM
Number of subjects: 58
Study: 25894440

Group type: EXPERIMENTAL
Intervention: Attention bias modification (4 weeks of computer-based training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo attention training (4 weeks)
Number of subjects: 0
Study: 23324373

Group type: EXPERIMENTAL
Intervention: Non-formal education with HIV prevention education
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Savings education
Number of subjects: 55
Study: 21287660

Group type: EXPERIMENTAL
Intervention: TAU plus stress management psychotherapy (three group sessions and 6-9 individual sessions with booster sessions at 6 and 12 months)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 114
Study: 19075192

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg daily
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg weekly
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Combination of Alendronate and Indapamide
Number of subjects: 77
Study: 17719934

Group type: EXPERIMENTAL
Intervention: INH-A21 (Veronate)
Number of subjects: 1983

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1983
Study: 15179024

Group type: EXPERIMENTAL
Intervention: Acamprosate 2000 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11216976

Group type: EXPERIMENTAL
Intervention: Single oral loading dose of propafenone (600 mg)
Number of subjects: 0
Study: 9532990

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 822

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 822
Study: 7993984

Group type: COMPARATOR
Intervention: Colestipol (10 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cholestyramine (8 g)
Number of subjects: 6
Study: 3246168

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (Rocephin)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefoperazone (Cefobis)
Number of subjects: 40
Study: 510196

Group type: EXPERIMENTAL
Intervention: 10 tablets of 800 mg bacampicillin (t.i.d.)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 20 tablets of 800 mg bacampicillin (t.i.d.)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 30 tablets of 800 mg bacampicillin (t.i.d.)
Number of subjects: 66
Study: 30572160

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) thrice weekly for 3–5 weeks
Number of subjects: 400

Group type: COMPARATOR
Intervention: Intravenous ketamine twice weekly for 3–5 weeks
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: ECT
Number of subjects: 400

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 400
Study: 27819714

Group type: EXPERIMENTAL
Intervention: Tonsillectomy (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (n = 14)
Number of subjects: 29
Study: 25575875

Group type: EXPERIMENTAL
Intervention: Immediate radiotherapy (21 Gy in 3 fractions over 3 working days within 42 days of the pleural intervention)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Deferred radiotherapy (21 Gy in 3 fractions over 3 working days given if a PTM develops)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Immediate radiotherapy
Number of subjects: 203

Group type: COMPARATOR
Intervention: Deferred radiotherapy
Number of subjects: 203
Study: 23702567

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: CPAP (> 4 h/night)
Number of subjects: 253
Study: 22930136

Group type: EXPERIMENTAL
Intervention: Levodopa (on period)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Levodopa (off period)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 20
Study: 21268294

Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (Dialipon, Byocerulin, Glutargin)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Byocerulin
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Dialipon
Number of subjects: 89
Study: 18277743

Group type: EXPERIMENTAL
Intervention: Ionic toothbrush
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional toothbrush
Number of subjects: 20